Report cover image

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Research Report 2025

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 122 Pages
SKU # APRC20542782

Description

Summary

According to APO Research, the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A include Carna Biosciences Inc, Felicitex Therapeutics, ManRos Therapeutics, NeuroNascent Inc and Pharmasum Therapeutics AS, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A.

The report will help the Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Company

Carna Biosciences Inc
Felicitex Therapeutics
ManRos Therapeutics
NeuroNascent Inc
Pharmasum Therapeutics AS
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Type

PST-900
NNI-351
FX-9847
Others
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Application

Pancreatic Cancer
Down Syndrome
Colon Cancer
Lung Cancer
Others
Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Table of Contents

122 Pages
1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size (2020-2031)
2.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (2020-2031)
2.2.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Average Price (2020-2031)
2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 PST-900
2.3.3 NNI-351
2.3.4 FX-9847
2.3.5 Others
2.4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Pancreatic Cancer
2.4.3 Down Syndrome
2.4.4 Colon Cancer
2.4.5 Lung Cancer
2.4.6 Others
3 Market Competitive Landscape by Manufacturers
3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units) of Manufacturers (2020-2025)
3.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue of Manufacturers (2020-2025)
3.4 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price by Manufacturers (2020-2025)
3.5 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Product Type & Application
3.8 Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Established Date
3.9 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Carna Biosciences Inc
4.1.1 Carna Biosciences Inc Company Information
4.1.2 Carna Biosciences Inc Business Overview
4.1.3 Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
4.1.5 Carna Biosciences Inc Recent Developments
4.2 Felicitex Therapeutics
4.2.1 Felicitex Therapeutics Company Information
4.2.2 Felicitex Therapeutics Business Overview
4.2.3 Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
4.2.5 Felicitex Therapeutics Recent Developments
4.3 ManRos Therapeutics
4.3.1 ManRos Therapeutics Company Information
4.3.2 ManRos Therapeutics Business Overview
4.3.3 ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2020-2025)
4.3.4 ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
4.3.5 ManRos Therapeutics Recent Developments
4.4 NeuroNascent Inc
4.4.1 NeuroNascent Inc Company Information
4.4.2 NeuroNascent Inc Business Overview
4.4.3 NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2020-2025)
4.4.4 NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
4.4.5 NeuroNascent Inc Recent Developments
4.5 Pharmasum Therapeutics AS
4.5.1 Pharmasum Therapeutics AS Company Information
4.5.2 Pharmasum Therapeutics AS Business Overview
4.5.3 Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
4.5.5 Pharmasum Therapeutics AS Recent Developments
5 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Scenario by Region
5.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2020-2031
5.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2020-2025
5.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2026-2031
5.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2020-2031
5.3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2020-2025
5.3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2026-2031
5.4 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
5.4.1 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2031)
5.4.3 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.5 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
5.5.1 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2031)
5.5.3 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Netherlands
5.6 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
5.6.1 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2031)
5.6.3 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 China Taiwan
5.6.10 Southeast Asia
5.7 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
5.7.1 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2031)
5.7.3 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2031)
5.7.4 Mexico
5.7.5 Brazil
5.7.6 Argentina
5.8 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
5.8.1 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2031)
5.8.3 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2031)
5.8.4 Turkey
5.8.5 Saudi Arabia
5.8.6 UAE
6 Segment by Type
6.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2020-2031)
6.1.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2020-2031) & (K Units)
6.1.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2020-2031)
6.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2020-2031)
6.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2020-2031)
6.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Type (2020-2031)
7 Segment by Application
7.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2020-2031)
7.1.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2020-2031) & (K Units)
7.1.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2020-2031)
7.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2020-2031)
7.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2020-2031)
7.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Value Chain Analysis
8.1.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production Mode & Process
8.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Distributors
8.2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Customers
9 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Analyzing Market Dynamics
9.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Trends
9.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Drivers
9.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Opportunities and Challenges
9.4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Restraints
10 Report Conclusion
11 Disclaimer
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
Table 4. Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
Table 5. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Volume and Revenue Market Size and CAGR of Manufacturers (2020 Versus 2024)
Table 6. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units) of Manufacturers (2020-2025)
Table 7. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue of Manufacturers (2020-2025)
Table 9. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Manufacturers (2020-2025)
Table 10. Global Market Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price (US$/Unit) of Manufacturers (2020-2025)
Table 11. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Ranking, 2023 VS 2024 VS 2025
Table 12. Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Manufacturing Sites & Headquarters
Table 13. Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Product Type & Application
Table 14. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Manufacturers Established Date
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2024)
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 18. Carna Biosciences Inc Company Information
Table 19. Carna Biosciences Inc Business Overview
Table 20. Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 21. Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
Table 22. Carna Biosciences Inc Recent Developments
Table 23. Felicitex Therapeutics Company Information
Table 24. Felicitex Therapeutics Business Overview
Table 25. Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 26. Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
Table 27. Felicitex Therapeutics Recent Developments
Table 28. ManRos Therapeutics Company Information
Table 29. ManRos Therapeutics Business Overview
Table 30. ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 31. ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
Table 32. ManRos Therapeutics Recent Developments
Table 33. NeuroNascent Inc Company Information
Table 34. NeuroNascent Inc Business Overview
Table 35. NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 36. NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
Table 37. NeuroNascent Inc Recent Developments
Table 38. Pharmasum Therapeutics AS Company Information
Table 39. Pharmasum Therapeutics AS Business Overview
Table 40. Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 41. Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
Table 42. Pharmasum Therapeutics AS Recent Developments
Table 43. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 44. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2020-2025) & (K Units)
Table 45. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Region (2020-2025)
Table 46. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2026-2031) & (K Units)
Table 47. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Region (2026-2031)
Table 48. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2020-2025) & (US$ Million)
Table 49. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2020-2025)
Table 50. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2026-2031) & (US$ Million)
Table 51. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2026-2031)
Table 52. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 53. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2025) & (K Units)
Table 54. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2026-2031) & (K Units)
Table 55. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2025) & (US$ Million)
Table 56. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2026-2031) & (US$ Million)
Table 57. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 58. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2025) & (K Units)
Table 59. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2026-2031) & (K Units)
Table 60. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2025) & (US$ Million)
Table 61. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2026-2031) & (US$ Million)
Table 62. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 63. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2025) & (K Units)
Table 64. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2026-2031) & (K Units)
Table 65. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2025) & (US$ Million)
Table 66. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2026-2031) & (US$ Million)
Table 67. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 68. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2025) & (K Units)
Table 69. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2026-2031) & (K Units)
Table 70. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2025) & (US$ Million)
Table 71. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2026-2031) & (US$ Million)
Table 72. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 73. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2020-2025) & (K Units)
Table 74. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2026-2031) & (K Units)
Table 75. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2020-2025) & (US$ Million)
Table 76. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2026-2031) & (US$ Million)
Table 77. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2020-2025) & (K Units)
Table 78. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2026-2031) & (K Units)
Table 79. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2020-2025)
Table 80. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2026-2031)
Table 81. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2020-2025) & (US$ Million)
Table 82. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2026-2031) & (US$ Million)
Table 83. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2020-2025)
Table 84. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2026-2031)
Table 85. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Type (2020-2025) & (US$/Unit)
Table 86. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Type (2026-2031) & (US$/Unit)
Table 87. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2020-2025) & (K Units)
Table 88. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2026-2031) & (K Units)
Table 89. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2020-2025)
Table 90. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2026-2031)
Table 91. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2020-2025) & (US$ Million)
Table 92. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2026-2031) & (US$ Million)
Table 93. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2020-2025)
Table 94. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2026-2031)
Table 95. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Application (2020-2025) & (US$/Unit)
Table 96. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Application (2026-2031) & (US$/Unit)
Table 97. Key Raw Materials
Table 98. Raw Materials Key Suppliers
Table 99. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Distributors List
Table 100. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Customers List
Table 101. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Trends
Table 102. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Drivers
Table 103. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Restraints
Table 104. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Image
Figure 5. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (US$ Million), 2020 VS 2024 VS 2031
Figure 6. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size (2020-2031) & (US$ Million)
Figure 7. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (2020-2031) & (K Units)
Figure 8. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price (US$/Unit) & (2020-2031)
Figure 9. PST-900 Product Image
Figure 10. NNI-351 Product Image
Figure 11. FX-9847 Product Image
Figure 12. Others Product Image
Figure 13. Pancreatic Cancer Product Image
Figure 14. Down Syndrome Product Image
Figure 15. Colon Cancer Product Image
Figure 16. Lung Cancer Product Image
Figure 17. Others Product Image
Figure 18. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Manufacturers in 2024
Figure 19. Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Manufacturing Sites & Headquarters
Figure 20. Global Top 5 and 10 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Players Market Share by Revenue in 2024
Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 22. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 23. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region in 2024
Figure 24. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region in 2024
Figure 25. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2024
Figure 26. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2020-2031)
Figure 27. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2020-2031)
Figure 28. United States Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2024
Figure 31. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2020-2031)
Figure 32. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2020-2031)
Figure 33. Germany Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. France Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. U.K. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Italy Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Netherlands Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2024
Figure 39. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2020-2031)
Figure 40. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2020-2031)
Figure 41. China Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. China Taiwan Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Southeast Asia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2024
Figure 50. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2020-2031)
Figure 51. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2020-2031)
Figure 52. Mexico Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Brazil Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Argentina Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2024
Figure 56. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2020-2031)
Figure 57. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2020-2031)
Figure 58. Turkey Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Saudi Arabia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 60. UAE Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 61. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2020-2031)
Figure 62. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2020-2031)
Figure 63. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price (US$/Unit) by Type (2020-2031)
Figure 64. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2020-2031)
Figure 65. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2020-2031)
Figure 66. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price (US$/Unit) by Application (2020-2031)
Figure 67. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Value Chain
Figure 68. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Opportunities and Challenges

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us